Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders : a Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)
-
Blauvelt, Andrew (SW Locust St., Suite G, Portland, USA)
;
Papp, Kim A. (Waterloo, Canada) ;
Griffiths, Christopher E. M. (Manchester, UK) ;
Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ;
Weisman, Jamie (Medical Dermatology Specialists, Inc., Atlanta, GA USA) ;
Dutronc, Yves (Indianapolis, IN USA) ;
Kerr, Lisa Farmer (Indianapolis, IN USA) ;
Ilo, Dapo (Indianapolis, IN USA) ;
Mallbris, Lotus (Indianapolis, IN USA) ;
Augustin, Matthias (University Medical Center Hamburg-Eppendorf) ;
Universitat Autònoma de Barcelona
visitant ::
identificació
Subscriure's to this discussion. You will then receive all new comments by email.
